Ceftriaxone Sodium I.P. 1000 mg & Sulbactam Sodium I.P. 500 mg Injections Specification
Ceftriaxone Sodium I.P. 1000 mg & Sulbactam Sodium I.P. 500 mg Injections Trade Information
- Supply Ability
- 1000 Per Month
- Main Export Market(s)
- [, ]
- Main Domestic Market
- A, l, I, a, [, ', l, , n, d, i, ', ]
About Ceftriaxone Sodium I.P. 1000 mg & Sulbactam Sodium I.P. 500 mg Injections
This powerful combination injection contains Ceftriaxone Sodium (1000 mg), a third-generation cephalosporin antibiotic, and Sulbactam Sodium (500 mg), a -lactamase inhibitor, providing enhanced efficacy against a broad spectrum of bacterial infections. Sulbactam prevents bacteria from breaking down Ceftriaxone, making it more effective against resistant strains. This dual-action injection is widely used to treat severe infections, including respiratory tract infections, urinary tract infections (UTIs), skin and soft tissue infections, intra-abdominal infections, and certain types of sepsis. Administered via intravenous (IV) or intramuscular (IM) routes, it ensures fast action and is trusted by healthcare professionals for critical care scenarios.